What is the share price of Advanced Enzyme Technologies Ltd (ADVENZYMES) today?
The share price of ADVENZYMES as on 8th July 2025 is ₹329.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
The past returns of Advanced Enzyme Technologies Ltd (ADVENZYMES) share are- Past 1 week: 2.04%
- Past 1 month: 10.16%
- Past 3 months: 24.98%
- Past 6 months: -2.16%
- Past 1 year: -13.53%
- Past 3 years: 23.72%
- Past 5 years: 94.95%
What are the peers or stocks similar to Advanced Enzyme Technologies Ltd (ADVENZYMES)?
The peers or stocks similar to Advanced Enzyme Technologies Ltd (ADVENZYMES) include:What is the dividend yield % of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
The current dividend yield of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 0.36.What is the market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹3778.79 Cr as of 8th July 2025.What is the 52 week high and low of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?
The 52-week high of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹571 and the 52-week low is ₹257.90.What is the PE and PB ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) stock?
The P/E (price-to-earnings) ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 28.82. The P/B (price-to-book) ratio is 2.57.Which sector does Advanced Enzyme Technologies Ltd (ADVENZYMES) belong to?
Advanced Enzyme Technologies Ltd (ADVENZYMES) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares?
You can directly buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Advanced Enzyme Technologies Ltd
ADVENZYMES Share Price
329.952.31% (-7.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ADVENZYMES Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ADVENZYMES Performance & Key Metrics
ADVENZYMES Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 28.82 | 2.57 | 0.36% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.88 | 3.49 | 1.56% |
ADVENZYMES Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ADVENZYMES Company Profile
Advanced Enzyme Technologies is engaged in the research and development, manufacturing and marketing of over 400 products developed from over 60 indigenous enzymes.
FLUOROCHEM
PE Ratio
70.66
70.66
1Y Return
8.78%
8.78%
Buy Reco %
55.56
55.56
NAVINFLUOR
PE Ratio
83.97
83.97
1Y Return
33.37%
33.37%
Buy Reco %
61.54
61.54
VINATIORGA
PE Ratio
51.73
51.73
1Y Return
5.46%
5.46%
Buy Reco %
83.33
83.33
AARTIIND
PE Ratio
51.12
51.12
1Y Return
34.11%
34.11%
Buy Reco %
70.59
70.59
AKZOINDIA
PE Ratio
38.27
38.27
1Y Return
25.54%
25.54%
Buy Reco %
50.00
50.00
ADVENZYMES Sentiment Analysis
ADVENZYMES Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ADVENZYMES Stock Summary · May 2025
In Q4 FY '25, the company demonstrated a cautious optimism for future growth, reporting a 6% year-on-year increase despite a sequential decline in EBITDA margins due to product mix changes. Significant investments in R&D, now at 9.34% of revenue, underscore a commitment to innovation, while sustainability initiatives, including a solar power plant, enhance operational efficiency. However, challenges such as high debt levels, geopolitical tensions, and tariff impacts loom over the growth outlook, particularly in the U.S. and international markets. The company is strategically expanding its product portfolio and distribution networks to capitalize on positive trends in biocatalysts and specialized manufacturing, aiming for a high-single-digit growth trajectory in the coming years.
ADVENZYMES Stock Growth Drivers
ADVENZYMES Stock Growth Drivers
8Sustainability Initiatives
The company has made significant strides in sustainability by completing the installation of a 350-kilowatt
Financial Performance and Growth
In Q4, the company reported a top line of INR 1,672 million, reflecting a 6%
ADVENZYMES Stock Challenges
ADVENZYMES Stock Challenges
5Declining Financial Performance
The company reported a decrease in revenue and profitability metrics across various segments. In Q4,
Challenges in Key Segments
The Human Nutrition segment, which constitutes 62% of revenue, experienced a 3% annual decline due
ADVENZYMES Forecast
ADVENZYMES Forecasts
Price
Revenue
Earnings
ADVENZYMES Share Price Forecast
ADVENZYMES Share Price Forecast
2025
Current
₹337.75
Baseline
Forecast for Feb 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹337.75
Baseline
Forecast for Feb 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ADVENZYMES Company Revenue Forecast
ADVENZYMES Company Revenue Forecast
2025
Current
₹669.95
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹669.95
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
ADVENZYMES Stock EPS (Earnings Per Share) Forecast
ADVENZYMES Stock EPS (Earnings Per Share) Forecast
2025
Current
₹11.72
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹11.72
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
ADVENZYMES
ADVENZYMES
Income
Balance Sheet
Cash Flow
Annual Normal View
ADVENZYMES Income Statement
ADVENZYMES Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 331.57 | 392.41 | 424.63 | 449.63 | 510.69 | 535.80 | 566.10 | 660.53 | 669.95 | 669.95 | ||||||||||
Raw Materials | 70.14 | 80.33 | 65.95 | 90.83 | 100.21 | 130.32 | 127.53 | 155.47 | 161.96 | 442.48 | ||||||||||
| Power & Fuel Cost | 12.87 | 18.10 | 19.29 | 19.37 | 21.45 | 29.95 | 38.10 | 41.51 | 38.45 | |||||||||||
| Employee Cost | 50.70 | 68.60 | 80.23 | 80.19 | 87.11 | 103.96 | 114.80 | 127.78 | 141.54 | |||||||||||
| Selling & Administrative Expenses | 25.61 | 38.41 | 40.04 | 37.58 | 37.72 | 51.80 | 56.22 | 59.96 | 64.17 | |||||||||||
| Operating & Other expenses | 18.00 | 20.64 | 30.84 | 12.65 | 22.78 | 10.77 | 50.56 | 48.63 | 35.28 | |||||||||||
EBITDA | 154.25 | 166.33 | 188.28 | 209.01 | 241.42 | 209.00 | 178.89 | 227.18 | 228.55 | 227.47 | ||||||||||
| Depreciation/Amortization | 12.76 | 18.30 | 21.12 | 25.78 | 28.72 | 34.98 | 35.03 | 35.24 | 36.56 | 36.56 | ||||||||||
| PBIT | 141.49 | 148.03 | 167.16 | 183.23 | 212.70 | 174.02 | 143.86 | 191.94 | 191.99 | 190.91 | ||||||||||
| Interest & Other Items | 4.43 | 9.06 | 5.20 | 4.08 | 2.57 | 2.96 | 3.48 | 4.12 | 4.63 | 3.55 | ||||||||||
| PBT | 137.06 | 138.97 | 161.96 | 179.15 | 210.13 | 171.06 | 140.38 | 187.82 | 187.36 | 187.36 | ||||||||||
| Taxes & Other Items | 45.51 | 48.91 | 50.90 | 49.87 | 64.21 | 51.48 | 34.75 | 54.52 | 56.26 | 56.24 | ||||||||||
| Net Income | 91.55 | 90.06 | 111.06 | 129.28 | 145.92 | 119.58 | 105.63 | 133.30 | 131.10 | 131.12 | ||||||||||
| EPS | 2.79 | 8.07 | 9.95 | 11.58 | 13.06 | 10.70 | 9.45 | 11.92 | 11.72 | 11.72 | ||||||||||
| DPS | 0.08 | 0.50 | 0.60 | 0.60 | 0.90 | 1.00 | 1.00 | 5.10 | 1.20 | 5.10 | ||||||||||
| Payout ratio | 0.03 | 0.06 | 0.06 | 0.05 | 0.07 | 0.09 | 0.11 | 0.43 | 0.10 | 0.44 |
ADVENZYMES Company Updates
ADVENZYMES Stock Peers
ADVENZYMES Past Performance & Peer Comparison
ADVENZYMES Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation-basic on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Advanced Enzyme Technologies Ltd | 28.82 | 2.57 | 0.36% |
| Gujarat Fluorochemicals Ltd | 70.66 | 6.50 | 0.09% |
| Navin Fluorine International Ltd | 83.97 | 10.17 | 0.25% |
| Vinati Organics Ltd | 51.73 | 8.52 | 0.37% |
ADVENZYMES Stock Price Comparison
Compare ADVENZYMES with any stock or ETFCompare ADVENZYMES with any stock or ETF
ADVENZYMES
ADVENZYMES Holdings
ADVENZYMES Shareholdings
ADVENZYMES Promoter Holdings Trend
ADVENZYMES Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ADVENZYMES Institutional Holdings Trend
ADVENZYMES Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ADVENZYMES Shareholding Pattern
ADVENZYMES Shareholding Pattern
ADVENZYMES Shareholding History
ADVENZYMES Shareholding History
Foreign Institutions
Mutual Funds Invested in ADVENZYMES
Mutual Funds Invested in ADVENZYMES
No mutual funds holding trends are available
Top 5 Mutual Funds holding Advanced Enzyme Technologies Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.0722% | Percentage of the fund’s portfolio invested in the stock 1.42% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/47 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.8830% | Percentage of the fund’s portfolio invested in the stock 1.16% | Change in the portfolio weight of the stock over the last 3 months 0.10% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 33/56 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.7041% | Percentage of the fund’s portfolio invested in the stock 1.74% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 17/53 (+2) |
Compare 3-month MF holding change on Screener
smallcases containing ADVENZYMES stock
smallcases containing ADVENZYMES stock
Looks like this stock is not in any smallcase yet.
ADVENZYMES Events
ADVENZYMES Events
ADVENZYMES Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ADVENZYMES has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.36%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.55 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ADVENZYMES Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ADVENZYMES has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.36%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.55 every year
ADVENZYMES Upcoming Dividends
ADVENZYMES Upcoming Dividends
Cash Dividend
Ex DateEx DateJul 23, 2025
Final
Final | Div/Share: ₹1.20
Dividend/Share
₹1.20
Ex DateEx Date
Jul 23, 2025
ADVENZYMES Past Dividends
ADVENZYMES Past Dividends
Cash Dividend
Ex DateEx DateMay 16, 2025
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
May 16, 2025
Cash Dividend
Ex DateEx DateJul 18, 2024
Final
Final | Div/Share: ₹1.10
Dividend/Share
₹1.10
Ex DateEx Date
Jul 18, 2024
Cash Dividend
Ex DateEx DateMay 17, 2024
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
May 17, 2024
Cash Dividend
Ex DateEx DateAug 4, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 4, 2023
Cash Dividend
Ex DateEx DateMay 19, 2023
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
May 19, 2023
ADVENZYMES Stock News & Opinions
ADVENZYMES Stock News & Opinions
Articles & Videos
Corporate
Advanced Enzyme Technologies fixes record date for interim dividend
Advanced Enzyme Technologies has fixed 17 May 2025 as record date for payment of interim dividend of Rs 4 per equity share for FY 2025-26. The dividend will be paid on or before 10 June 2025. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to convene AGM
Advanced Enzyme Techs. announced that the 36th Annual General Meeting(AGM) of the company will be held on 30 July 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Advanced Enzyme Techs. recommends final dividend
Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting held on 13 May 2025, inter alia, have recommended the final dividend of Rs 1.2 per equity Share (i.e. 60%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Advanced Enzyme Techs. recommends interim dividend
Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting held on 13 May 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 200%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit declines 6.46% in the March 2025 quarter
Net profit of Advanced Enzyme Technologies declined 6.46% to Rs 26.48 crore in the quarter ended March 2025 as against Rs 28.31 crore during the previous quarter ended March 2024. Sales rose 5.93% to Rs 167.18 crore in the quarter ended March 2025 as against Rs 157.82 crore during the previous quarter ended March 2024. For the full year,net profit declined 1.64% to Rs 131.12 crore in the year ended March 2025 as against Rs 133.31 crore during the previous year ended March 2024. Sales rose 2.09% to Rs 636.91 crore in the year ended March 2025 as against Rs 623.87 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales167.18157.82 6 636.91623.87 2 OPM %27.2835.08 -30.5332.77 - PBDT53.5464.02 -16 223.92238.19 -6 PBT43.4654.74 -21 187.36202.95 -8 NP26.4828.31 -6 131.12133.31 -2 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to declare Quarterly Results
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to declare Quarterly Results
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Advanced Enzyme Technologies allots 500 equity shares under ESOS
Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,61,300 comprising of 11,18,80,650 equity shares of Rs 2 each to Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each. Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter
Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales169.11160.94 5 OPM %32.6733.40 - PBDT61.9967.48 -8 PBT53.0258.88 -10 NP37.6541.77 -10 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to announce Quarterly Result
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 8 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 8.3%, vs industry avg of 11.47%
Over the last 5 years, market share decreased from 0.87% to 0.72%
Over the last 5 years, net income has grown at a yearly rate of 0.28%, vs industry avg of 7.76%